Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Glycomed antiinflammatory patents licensed to Cytel

Feb. 25, 1998

Azithromycin prevents acceleration of atherosclerosis by C. pneumoniae infection

Feb. 25, 1998

Tedisamil has favorable profile as myocardial antiischemic agent

Feb. 25, 1998

Abbott will market Orion's calcium sensitizer levosimendan

Feb. 24, 1998

Icos monoclonal antibody enters phase II for hemorrhagic shock

Feb. 19, 1998

New once-daily antihypertensive combination available in U.S.

Feb. 18, 1998

A novel NOS inhibitor possibly involved in elevating arterial pressure

Feb. 18, 1998

rAAV vector to be evaluated for cardiovascular gene transfer

Feb. 17, 1998

KR-30450 exerts cardioprotective effects in ischemic rat hearts

Feb. 16, 1998

Successful results contribute to early termination of phase IIa study of TBC-11251

Feb. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...